First-Line Durvalumab Improves PFS in Advanced Endometrial Cancer.

Authors :: Mauro, Gina
Source :: Targeted Therapies in Oncology; May2024, Vol. 13 Issue 6, p51-56, 2p
Publication Year :: 2024

Subjects :: THERAPEUTIC use of antineoplastic agents
THERAPEUTIC use of monoclonal antibodies
PATIENT safety
IMMUNOTHERAPY
CONFERENCES & conventions
TREATMENT duration
ENDOMETRIAL tumors
CANCER chemotherapy
PROGRESSION-free survival
OVERALL survival

Tools